Sickle Cell Anemia Testing & Screening Market Size, Share & Trends Analysis Report By Technology (Hemoglobin Electrophoresis, POC, HPLC), By Age Group, By Sector Type, And Segment Forecasts, 2020 - 2027
This report can be delivered to the clients within 10-12 business days post order confirmation
Sickle Cell Anemia Testing & Screening Market Growth & Trends
The global sickle cell anemia testing and screening market size is expected to reach USD 340.71 million by 2027, expanding at a CAGR of 5.44% from 2020 to 2027, according to a new report by Grand View Research, Inc. Hemoglobin S (HbS) is the causative factor for sickle cell disease and is currently the most prevailing disease or genetic abnormality across the globe, specifically across developing economies.
Sickle cell hemoglobin variants are inclusive of HbS, HbA, and HbC. Different tests have been developed to perform a clear distinction between all the three above-mentioned hemoglobin variants. Development of a deep learning framework designed to perform automated screening of sickle cell anemia in blood smear sample of patients via a smartphone microscope is set to open up new avenues for the market in the near future.
The market is moderately consolidated, wherein the key industry participants are striving to sustain market competition via partnerships, acquisitions, and expanding their business across newborn testing market space. Whereas, emerging companies are exploring potential of point-of-care tests to gain a competitive edge in the market.
A steep increase in the uptake of Hb electrophoresis and HPLC across government-initiated newborn screening programs and assessment studies have resulted in robust market penetration. This has, in turn, caught the attention of companies who are keen on modifying their existing product line, further amplifying consumption of the same.
Sickle Aell Anemia Testing & Screening Market Report Highlights
Sickle Cell Anemia Testing & Screening Market Growth & Trends
The global sickle cell anemia testing and screening market size is expected to reach USD 340.71 million by 2027, expanding at a CAGR of 5.44% from 2020 to 2027, according to a new report by Grand View Research, Inc. Hemoglobin S (HbS) is the causative factor for sickle cell disease and is currently the most prevailing disease or genetic abnormality across the globe, specifically across developing economies.
Sickle cell hemoglobin variants are inclusive of HbS, HbA, and HbC. Different tests have been developed to perform a clear distinction between all the three above-mentioned hemoglobin variants. Development of a deep learning framework designed to perform automated screening of sickle cell anemia in blood smear sample of patients via a smartphone microscope is set to open up new avenues for the market in the near future.
The market is moderately consolidated, wherein the key industry participants are striving to sustain market competition via partnerships, acquisitions, and expanding their business across newborn testing market space. Whereas, emerging companies are exploring potential of point-of-care tests to gain a competitive edge in the market.
A steep increase in the uptake of Hb electrophoresis and HPLC across government-initiated newborn screening programs and assessment studies have resulted in robust market penetration. This has, in turn, caught the attention of companies who are keen on modifying their existing product line, further amplifying consumption of the same.
Sickle Aell Anemia Testing & Screening Market Report Highlights
- By age group, several newborn screening programs have been employed across the globe to effectively manage the burden of this disease. These programs make use of different tests such as isoelectric focusing/ cellulose acetate electrophoresis, high-performance liquid chromatography (HPLC), and solubility tests
- Based on technology, POC lateral flow assays are the most preferred testing methodologies in screening programs, forming the conventional means of testing
- On the basis of sector type, government laboratories have witnessed maximum employment of sickle cell tests over the years
- Government laboratories have actively participated in promoting the adoption of these tests by encouraging population-based sickle cell testing
- Rise in the demand for federal and foundation funding to address healthcare disparities treatments and diagnosis of diseases, such as hemoglobinopathies and cystic fibrosis, is expected to drive the attention of the regulatory agencies.
CHAPTER 1 METHODOLOGY AND SCOPE
1.1 Research Methodology
1.2 Research Assumptions
1.2.1 Estimates And Forecast Timeline
1.3 Research Methodology
1.4 Information Procurement
1.4.1 Purchased Database
1.4.2 GVR’s Internal Database
1.4.3 Secondary Sources
1.4.4 Primary Research
1.4.5 Details Of Primary Research
1.5 Information Or Data Analysis
1.5.1 Sickle Cell Anemia Testing & Screening Market: Segment Revenue And Growth Analysis
1.5.2 Sickle Cell Anemia Testing & Screening Market: Technology Revenue And Growth Analysis
1.5.3 Sickle Cell Anemia Testing & Screening Market: Age Group Revenue And Growth Analysis
1.5.4 Sickle Cell Anemia Testing & Screening Market: Sector Revenue And Growth Analysis
1.5.5 Sickle Cell Anemia Testing & Screening Market: Regional Revenue And Growth Analysis
1.5.6 Data Analysis Models
1.6 Market Formulation & Validation
1.7 Model Details
1.7.1 Commodity Flow Analysis
1.7.1.1 Approach 1: Commodity Flow Approach
1.7.1.2 Approach 2: Country Wise Market Estimation Using Bottom Up Approach
1.8 Global Market: Cagr Calculation
1.9 List Of Secondary Sources
1.10 List Of Primary Sources
1.11 Objectives
1.11.1 Objective 1:
1.11.2 Objective 2:
CHAPTER 2 MARKET DEFINITIONS
CHAPTER 3 EXECUTIVE SUMMARY
3.1 Market Summary
CHAPTER 4 MARKET VARIABLES, TRENDS & SCOPE
4.1 Market Segmentation
4.2 Sickle Cell Anemia (Hbs) Testing & Screening Market Lineage Outlook
4.2.1 Parent Market Outlook
4.3 Penetration And Growth Prospect Mapping
4.4 Coronavirus Impact On The Sickle Cell Disease Industry
CHAPTER 5 INDUSTRY OUTLOOK
5.1 Market Drivers Analysis
5.1.1 Increasing Implementation Of Strategies To Minimize The Sickle Cell Disease Burden
5.1.1.1 Newborn/Neonatal Screening
5.1.1.2 Point?Of?Care (Poc) Tests
5.1.1.3 Prioritization Of Newborn/Neonatal Screening To Reduce Sca Burden
5.1.2 Rising Prevalence Of Sickle Cell Disease Across The Globe
5.2 Market Restraint Analysis
5.2.1 Infrastructal Challenges Associated With Screening And Diagnosis Of Sickle Cell Disease
5.3 Market Opportunity Analysis
5.3.1 Automated Screening Of Sickle Cell Disease
CHAPTER 6 BUSINESS ENVIRONMENT ANALYSIS
6.1 Swot Analysis; By Factor (Political & Legal, Economic And Technological)
6.2 Porter’s Five Forces Analysis
CHAPTER 7 COMPETITIVE ANALYSIS
7.1 Market Impact Analysis By Key Participants
7.1.1 Ansoff Matrix
7.1.2 Company/Competition Categorization (Primary & Secondary Market Participants)
7.2 Market Entry Strategies
7.2.1 Cost Analysis Point-Of-Care Tests: Sickle Cell Disease Screening
CHAPTER 8 TECHNOLOGY BUSINESS ANALYSIS
8.1 Sickle Cell Anemia (Hbs) Testing & Screening Market: Technology Movement Analysis
8.2 Hemoglobin Electrophoresis
8.2.1 Hb Electrophoresis-Based Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecasts, 2016 - 2027 (USD Million)
8.2.2 Hb Electrophoresis-Based Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecasts, 2016 - 2027 (Volume Of Tests, Thousand Units)
8.2.3 Isoelectric Focussing
8.2.3.1 Isoelectric Focussing-Based Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecasts, 2016 - 2027 (USD Million)
8.2.3.2 Isoelectric Focussing-Based Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecasts, 2016 - 2027 (Volume Of Tests, Thousand Units)
8.2.4 Other Electrophoresis-Based
8.2.4.1 Screening Market Estimates And Forecasts, 2016 - 2027 (USD Million)
8.2.4.2 Other Electrophoresis-Based Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecasts, 2016 - 2027 (Volume Of Tests, Thousand Units)
8.3 High-Performance Liquid Chromatography (Hplc)
8.3.1 Hplc-Based Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecasts, 2016 - 2027 (USD Million)
8.3.2 Hplc-Based Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecasts, 2016 - 2027 (Volume Of Tests, Thousand Units)
8.4 Point-Of-Care Tests
8.4.1 Poc Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecasts, 2016 - 2027 (USD Million)
8.4.2 Poc Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecasts, 2016 - 2027 (Volume Of Tests, Thousand Units)
8.4.3 Lateral Flow Immunoassay Poc
8.4.3.1 Lateral Flow Immunoassay Poc Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecasts, 2016 - 2027 (USD Million)
8.4.3.2 Lateral Flow Immunoassay Poc Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecasts, 2016 - 2027 (Volume Of Tests, Thousand Units)
8.4.4 Paper Based Poc
8.4.4.1 Paper Based Poc Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecasts, 2016 - 2027 (USD Million)
8.4.4.2 Paper Based Poc Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecasts, 2016 - 2027 (Volume Of Tests, Thousand Units)
8.4.5 Other Poc
8.4.5.1 Other Poc Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecasts, 2016 - 2027 (USD Million)
8.4.5.2 Other Poc Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecasts, 2016 - 2027 (Volume Of Tests, Thousand Units)
8.5 Other Tests
8.5.1 Other Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecasts, 2016 - 2027 (USD Million)
8.5.2 Other Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecasts, 2016 - 2027 (Volume Of Tests, Thousand Units)
CHAPTER 9 AGE GROUP BUSINESS ANALYSIS
9.1 Sickle Cell Anemia (Hbs) Testing & Screening Market: Age Group Movement Analysis
9.2 Newborn Screening (12 Months And Below)
9.2.1 Sickle Cell Anemia (Hbs) Newborn Testing & Screening Market Estimates And Forecast, 2016 - 2027 (USD Million)
9.3 Adult Screening (25 To 60 Years)
9.3.1 Sickle Cell Anemia (Hbs) Adult Testing & Screening Market Estimates And Forecast, 2016 - 2027 (USD Million)
9.4 Other Age Groups (1 To 25 & Above 60 Years)
9.4.1 Sickle Cell Anemia (Hbs) Testing & Screening Market For Other Age Groups Estimates And Forecast, 2016 - 2027 (USD Million)
CHAPTER 10 SECTOR TYPE BUSINESS ANALYSIS
10.1 Sickle Cell Anemia (Hbs) Testing & Screening Market: Sector Type Movement Analysis
10.2 Government Labs
10.2.1 Sickle Cell Anemia (Hbs) Testing & Screening Market For Government Labs Estimates And Forecast, 2016-2027
10.3 Private Labs
10.3.1 Sickle Cell Anemia (Hbs) Testing & Screening Market For Private Labs Estimates And Forecast, 2016-2027
10.4 Corporate Labs
10.4.1 Sickle Cell Anemia (Hbs) Testing & Screening Market For Corporate Labs Estimates And Forecast, 2016-2027
10.5 Ppp (Public-Private-Partnerships)
10.5.1 Sickle Cell Anemia (Hbs) Testing & Screening Market For Ppp (Public-Private-Partnerships) Estimates And Forecast, 2016-2027
CHAPTER 11 REGIONAL BUSINESS ANALYSIS
11.1 Sickle Cell Anemia (Hbs) Testing & Screening Market: Regional Movement Analysis
11.2 North America
11.2.1 North America Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecast, 2016 - 2027 (USD Million)
11.2.2 U.S.
11.2.2.1 U.S. Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecast, 2016 - 2027 (USD Million)
11.2.3 Canada
11.2.3.1 Canada Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecast, 2016 - 2027 (USD Million)
11.3 Europe
11.3.1 Europe Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecast, 2016 - 2027 (USD Million)
11.3.2 Germany
11.3.2.1 Germany Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecast, 2016 - 2027 (USD Million)
11.3.3 U.K.
11.3.3.1 U.K. Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecast, 2016 - 2027 (USD Million)
11.4 Asia-Pacific
11.4.1 Asia Pacific Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecast, 2016 - 2027 (USD Million)
11.4.2 Japan
11.4.2.1 Japan Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecast, 2016 - 2027 (USD Million)
11.4.3 China
11.4.3.1 China Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecast, 2016 - 2027 (USD Million)
11.4.4 India
11.4.4.1 India Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecast, 2016 - 2027 (USD Million)
11.5 Latin America
11.5.1 Latin America Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecast, 2016 - 2027 (USD Million)
11.5.2 Brazil
11.5.2.1 Brazil Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecast, 2016 - 2027 (USD Million)
11.6 Middle East And Africa
11.6.1 Mea Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecast, 2016 - 2027 (USD Million)
11.6.2 South Africa
11.6.2.1 South Africa Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecast, 2016 - 2027 (USD Million)
CHAPTER 12 COMPANY PROFILES
12.1 Company Profiles
12.1.1. STRECK
12.1.1.1 Company overview
12.1.1.2 Financial performance
12.1.1.3 Product benchmarking
12.1.1.4 Strategic Initiatives
12.1.2 BIOMEDOMICS INC.
12.1.2.1 Company overview
12.1.2.2 Product benchmarking
12.1.2.3 Strategic initiatives
12.1.3 Hemex Health
12.1.3.1 Company overview
12.1.3.2 Product benchmarking
12.1.3.3 Strategic initiatives
12.1.4 Silver Lake Research Corporation
12.1.4.1 Company overview
12.1.4.2 Product benchmarking
12.1.5 Request A Test
12.1.5.1 Company overview
12.1.5.2 Product benchmarking
12.1.6 Laboratory Corporation of America Holdings
12.1.6.1 Company overview
12.1.6.2 Financial performance
12.1.6.3 Product benchmarking
12.1.7 Quest Diagnostics Incorporated
12.1.7.1 Company overview
12.1.7.2 Financial performance
12.1.7.3 Product benchmarking
12.1.7.4 Strategic Initiatives
12.1.8 HALCYON BIOMEDICAL INCORPORATED
12.1.8.1 Company overview
12.1.8.2 Product benchmarking
12.1.8.3 Strategic Initiatives
12.1.9 PerkinElmer Inc.
12.1.9.1 Company overview
12.1.9.2 Financial performance
12.1.9.3 Product benchmarking
12.1.10 Bio-Rad Laboratories, Inc.
12.1.10.1 Company overview
12.1.10.2 Financial performance
12.1.10.3 Product benchmarking
12.1.11 Daktari Diagnostics .
12.1.11.1 Company overview
12.1.11.2 Financial performance
12.1.11.3 Product benchmarking
12.1.11.4 Strategic Initiatives
1.1 Research Methodology
1.2 Research Assumptions
1.2.1 Estimates And Forecast Timeline
1.3 Research Methodology
1.4 Information Procurement
1.4.1 Purchased Database
1.4.2 GVR’s Internal Database
1.4.3 Secondary Sources
1.4.4 Primary Research
1.4.5 Details Of Primary Research
1.5 Information Or Data Analysis
1.5.1 Sickle Cell Anemia Testing & Screening Market: Segment Revenue And Growth Analysis
1.5.2 Sickle Cell Anemia Testing & Screening Market: Technology Revenue And Growth Analysis
1.5.3 Sickle Cell Anemia Testing & Screening Market: Age Group Revenue And Growth Analysis
1.5.4 Sickle Cell Anemia Testing & Screening Market: Sector Revenue And Growth Analysis
1.5.5 Sickle Cell Anemia Testing & Screening Market: Regional Revenue And Growth Analysis
1.5.6 Data Analysis Models
1.6 Market Formulation & Validation
1.7 Model Details
1.7.1 Commodity Flow Analysis
1.7.1.1 Approach 1: Commodity Flow Approach
1.7.1.2 Approach 2: Country Wise Market Estimation Using Bottom Up Approach
1.8 Global Market: Cagr Calculation
1.9 List Of Secondary Sources
1.10 List Of Primary Sources
1.11 Objectives
1.11.1 Objective 1:
1.11.2 Objective 2:
CHAPTER 2 MARKET DEFINITIONS
CHAPTER 3 EXECUTIVE SUMMARY
3.1 Market Summary
CHAPTER 4 MARKET VARIABLES, TRENDS & SCOPE
4.1 Market Segmentation
4.2 Sickle Cell Anemia (Hbs) Testing & Screening Market Lineage Outlook
4.2.1 Parent Market Outlook
4.3 Penetration And Growth Prospect Mapping
4.4 Coronavirus Impact On The Sickle Cell Disease Industry
CHAPTER 5 INDUSTRY OUTLOOK
5.1 Market Drivers Analysis
5.1.1 Increasing Implementation Of Strategies To Minimize The Sickle Cell Disease Burden
5.1.1.1 Newborn/Neonatal Screening
5.1.1.2 Point?Of?Care (Poc) Tests
5.1.1.3 Prioritization Of Newborn/Neonatal Screening To Reduce Sca Burden
5.1.2 Rising Prevalence Of Sickle Cell Disease Across The Globe
5.2 Market Restraint Analysis
5.2.1 Infrastructal Challenges Associated With Screening And Diagnosis Of Sickle Cell Disease
5.3 Market Opportunity Analysis
5.3.1 Automated Screening Of Sickle Cell Disease
CHAPTER 6 BUSINESS ENVIRONMENT ANALYSIS
6.1 Swot Analysis; By Factor (Political & Legal, Economic And Technological)
6.2 Porter’s Five Forces Analysis
CHAPTER 7 COMPETITIVE ANALYSIS
7.1 Market Impact Analysis By Key Participants
7.1.1 Ansoff Matrix
7.1.2 Company/Competition Categorization (Primary & Secondary Market Participants)
7.2 Market Entry Strategies
7.2.1 Cost Analysis Point-Of-Care Tests: Sickle Cell Disease Screening
CHAPTER 8 TECHNOLOGY BUSINESS ANALYSIS
8.1 Sickle Cell Anemia (Hbs) Testing & Screening Market: Technology Movement Analysis
8.2 Hemoglobin Electrophoresis
8.2.1 Hb Electrophoresis-Based Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecasts, 2016 - 2027 (USD Million)
8.2.2 Hb Electrophoresis-Based Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecasts, 2016 - 2027 (Volume Of Tests, Thousand Units)
8.2.3 Isoelectric Focussing
8.2.3.1 Isoelectric Focussing-Based Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecasts, 2016 - 2027 (USD Million)
8.2.3.2 Isoelectric Focussing-Based Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecasts, 2016 - 2027 (Volume Of Tests, Thousand Units)
8.2.4 Other Electrophoresis-Based
8.2.4.1 Screening Market Estimates And Forecasts, 2016 - 2027 (USD Million)
8.2.4.2 Other Electrophoresis-Based Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecasts, 2016 - 2027 (Volume Of Tests, Thousand Units)
8.3 High-Performance Liquid Chromatography (Hplc)
8.3.1 Hplc-Based Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecasts, 2016 - 2027 (USD Million)
8.3.2 Hplc-Based Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecasts, 2016 - 2027 (Volume Of Tests, Thousand Units)
8.4 Point-Of-Care Tests
8.4.1 Poc Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecasts, 2016 - 2027 (USD Million)
8.4.2 Poc Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecasts, 2016 - 2027 (Volume Of Tests, Thousand Units)
8.4.3 Lateral Flow Immunoassay Poc
8.4.3.1 Lateral Flow Immunoassay Poc Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecasts, 2016 - 2027 (USD Million)
8.4.3.2 Lateral Flow Immunoassay Poc Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecasts, 2016 - 2027 (Volume Of Tests, Thousand Units)
8.4.4 Paper Based Poc
8.4.4.1 Paper Based Poc Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecasts, 2016 - 2027 (USD Million)
8.4.4.2 Paper Based Poc Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecasts, 2016 - 2027 (Volume Of Tests, Thousand Units)
8.4.5 Other Poc
8.4.5.1 Other Poc Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecasts, 2016 - 2027 (USD Million)
8.4.5.2 Other Poc Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecasts, 2016 - 2027 (Volume Of Tests, Thousand Units)
8.5 Other Tests
8.5.1 Other Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecasts, 2016 - 2027 (USD Million)
8.5.2 Other Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecasts, 2016 - 2027 (Volume Of Tests, Thousand Units)
CHAPTER 9 AGE GROUP BUSINESS ANALYSIS
9.1 Sickle Cell Anemia (Hbs) Testing & Screening Market: Age Group Movement Analysis
9.2 Newborn Screening (12 Months And Below)
9.2.1 Sickle Cell Anemia (Hbs) Newborn Testing & Screening Market Estimates And Forecast, 2016 - 2027 (USD Million)
9.3 Adult Screening (25 To 60 Years)
9.3.1 Sickle Cell Anemia (Hbs) Adult Testing & Screening Market Estimates And Forecast, 2016 - 2027 (USD Million)
9.4 Other Age Groups (1 To 25 & Above 60 Years)
9.4.1 Sickle Cell Anemia (Hbs) Testing & Screening Market For Other Age Groups Estimates And Forecast, 2016 - 2027 (USD Million)
CHAPTER 10 SECTOR TYPE BUSINESS ANALYSIS
10.1 Sickle Cell Anemia (Hbs) Testing & Screening Market: Sector Type Movement Analysis
10.2 Government Labs
10.2.1 Sickle Cell Anemia (Hbs) Testing & Screening Market For Government Labs Estimates And Forecast, 2016-2027
10.3 Private Labs
10.3.1 Sickle Cell Anemia (Hbs) Testing & Screening Market For Private Labs Estimates And Forecast, 2016-2027
10.4 Corporate Labs
10.4.1 Sickle Cell Anemia (Hbs) Testing & Screening Market For Corporate Labs Estimates And Forecast, 2016-2027
10.5 Ppp (Public-Private-Partnerships)
10.5.1 Sickle Cell Anemia (Hbs) Testing & Screening Market For Ppp (Public-Private-Partnerships) Estimates And Forecast, 2016-2027
CHAPTER 11 REGIONAL BUSINESS ANALYSIS
11.1 Sickle Cell Anemia (Hbs) Testing & Screening Market: Regional Movement Analysis
11.2 North America
11.2.1 North America Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecast, 2016 - 2027 (USD Million)
11.2.2 U.S.
11.2.2.1 U.S. Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecast, 2016 - 2027 (USD Million)
11.2.3 Canada
11.2.3.1 Canada Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecast, 2016 - 2027 (USD Million)
11.3 Europe
11.3.1 Europe Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecast, 2016 - 2027 (USD Million)
11.3.2 Germany
11.3.2.1 Germany Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecast, 2016 - 2027 (USD Million)
11.3.3 U.K.
11.3.3.1 U.K. Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecast, 2016 - 2027 (USD Million)
11.4 Asia-Pacific
11.4.1 Asia Pacific Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecast, 2016 - 2027 (USD Million)
11.4.2 Japan
11.4.2.1 Japan Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecast, 2016 - 2027 (USD Million)
11.4.3 China
11.4.3.1 China Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecast, 2016 - 2027 (USD Million)
11.4.4 India
11.4.4.1 India Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecast, 2016 - 2027 (USD Million)
11.5 Latin America
11.5.1 Latin America Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecast, 2016 - 2027 (USD Million)
11.5.2 Brazil
11.5.2.1 Brazil Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecast, 2016 - 2027 (USD Million)
11.6 Middle East And Africa
11.6.1 Mea Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecast, 2016 - 2027 (USD Million)
11.6.2 South Africa
11.6.2.1 South Africa Sickle Cell Anemia (Hbs) Testing & Screening Market Estimates And Forecast, 2016 - 2027 (USD Million)
CHAPTER 12 COMPANY PROFILES
12.1 Company Profiles
12.1.1. STRECK
12.1.1.1 Company overview
12.1.1.2 Financial performance
12.1.1.3 Product benchmarking
12.1.1.4 Strategic Initiatives
12.1.2 BIOMEDOMICS INC.
12.1.2.1 Company overview
12.1.2.2 Product benchmarking
12.1.2.3 Strategic initiatives
12.1.3 Hemex Health
12.1.3.1 Company overview
12.1.3.2 Product benchmarking
12.1.3.3 Strategic initiatives
12.1.4 Silver Lake Research Corporation
12.1.4.1 Company overview
12.1.4.2 Product benchmarking
12.1.5 Request A Test
12.1.5.1 Company overview
12.1.5.2 Product benchmarking
12.1.6 Laboratory Corporation of America Holdings
12.1.6.1 Company overview
12.1.6.2 Financial performance
12.1.6.3 Product benchmarking
12.1.7 Quest Diagnostics Incorporated
12.1.7.1 Company overview
12.1.7.2 Financial performance
12.1.7.3 Product benchmarking
12.1.7.4 Strategic Initiatives
12.1.8 HALCYON BIOMEDICAL INCORPORATED
12.1.8.1 Company overview
12.1.8.2 Product benchmarking
12.1.8.3 Strategic Initiatives
12.1.9 PerkinElmer Inc.
12.1.9.1 Company overview
12.1.9.2 Financial performance
12.1.9.3 Product benchmarking
12.1.10 Bio-Rad Laboratories, Inc.
12.1.10.1 Company overview
12.1.10.2 Financial performance
12.1.10.3 Product benchmarking
12.1.11 Daktari Diagnostics .
12.1.11.1 Company overview
12.1.11.2 Financial performance
12.1.11.3 Product benchmarking
12.1.11.4 Strategic Initiatives
LIST OF TABLES
Table 1 Comparative analysis of commercial tests available for screening sickle cell anemia population
Table 2 Top 10 laboratories offering sickle cell anemia screening tests, India
Table 3 List of secondary sources
Table 4 Prioritization of recommendations for newborn/neonatal screening
Table 5 North America sickle cell anemia (HbS) testing & screening market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
Table 6 North America sickle cell anemia (HbS) testing & screening market estimates and forecasts for, hemoglobin electrophereis, by technology, 2016 - 2027 (USD Million)
Table 7 North America. sickle cell anemia (HbS) testing & screening market estimates and forecasts for, POC tests, by technology, 2016 - 2027 (USD Million)
Table 8 North America sickle cell anemia (HbS) testing & screening market estimates and forecasts, by age group, 2016 - 2027 (USD Million)
Table 9 North America sickle cell anemia (HbS) testing & screening market estimates and forecasts, by sector type, 2016 - 2027 (USD Million)
Table 10 U.S. sickle cell anemia (HbS) testing & screening market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
Table 11 U.S. sickle cell anemia (HbS) testing & screening market estimates and forecasts for, hemoglobin electrophereis, by technology, 2016 - 2027 (USD Million)
Table 12 U.S. sickle cell anemia (HbS) testing & screening market estimates and forecasts for, POC tests, by technology, 2016 - 2027 (USD Million)
Table 13 U.S. sickle cell anemia (HbS) testing & screening market estimates and forecasts, by age group, 2016 - 2027 (USD Million)
Table 14 U.S. sickle cell anemia (HbS) testing & screening market estimates and forecasts, by sector type, 2016 - 2027 (USD Million)
Table 15 Canada sickle cell anemia (HbS) testing & screening market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
Table 16 Canada sickle cell anemia (HbS) testing & screening market estimates and forecasts for, hemoglobin electrophereis, by technology, 2016 - 2027 (USD Million)
Table 17 Canada sickle cell anemia (HbS) testing & screening market estimates and forecasts for, POC tests, by technology, 2016 - 2027 (USD Million)
Table 18 Canada sickle cell anemia (HbS) testing & screening market estimates and forecasts, by age group, 2016 - 2027 (USD Million)
Table 19 Canada sickle cell anemia (HbS) testing & screening market estimates and forecasts, by sector type, 2016 - 2027 (USD Million)
Table 20 Europe sickle cell anemia (HbS) testing & screening market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
Table 21 Europe sickle cell anemia (HbS) testing & screening market estimates and forecasts for, hemoglobin electrophereis, by technology, 2016 - 2027 (USD Million)
Table 22 Europe. sickle cell anemia (HbS) testing & screening market estimates and forecasts for, POC tests, by technology, 2016 - 2027 (USD Million)
Table 23 Europe sickle cell anemia (HbS) testing & screening market estimates and forecasts, by age group, 2016 - 2027 (USD Million)
Table 24 Europe sickle cell anemia (HbS) testing & screening market estimates and forecasts, by sector type, 2016 - 2027 (USD Million)
Table 25 Germany sickle cell anemia (HbS) testing & screening market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
Table 26 Germany sickle cell anemia (HbS) testing & screening market estimates and forecasts for, hemoglobin electrophereis, by technology, 2016 - 2027 (USD Million)
Table 27 Germany sickle cell anemia (HbS) testing & screening market estimates and forecasts for, POC tests, by technology, 2016 - 2027 (USD Million)
Table 28 Germany sickle cell anemia (HbS) testing & screening market estimates and forecasts, by age group, 2016 - 2027 (USD Million)
Table 29 Germany sickle cell anemia (HbS) testing & screening market estimates and forecasts, by sector type, 2016 - 2027 (USD Million)
Table 30 U.K. sickle cell anemia (HbS) testing & screening market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
Table 31 U.K. sickle cell anemia (HbS) testing & screening market estimates and forecasts for, hemoglobin electrophereis, by technology, 2016 - 2027 (USD Million)
Table 32 U.K. sickle cell anemia (HbS) testing & screening market estimates and forecasts for, POC tests, by technology, 2016 - 2027 (USD Million)
Table 33 U.K. sickle cell anemia (HbS) testing & screening market estimates and forecasts, by age group, 2016 - 2027 (USD Million)
Table 34 U.K. sickle cell anemia (HbS) testing & screening market estimates and forecasts, by sector type, 2016 - 2027 (USD Million)
Table 35 Asia Pacific sickle cell anemia (HbS) testing & screening market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
Table 36 Asia Pacific sickle cell anemia (HbS) testing & screening market estimates and forecasts for, hemoglobin electrophereis, by technology, 2016 - 2027 (USD Million)
Table 37 Asia Pacific. sickle cell anemia (HbS) testing & screening market estimates and forecasts for, POC tests, by technology, 2016 - 2027 (USD Million)
Table 38 Asia Pacific sickle cell anemia (HbS) testing & screening market estimates and forecasts, by age group, 2016 - 2027 (USD Million)
Table 39 Asia Pacific sickle cell anemia (HbS) testing & screening market estimates and forecasts, by sector type, 2016 - 2027 (USD Million)
Table 40 Japan sickle cell anemia (HbS) testing & screening market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
Table 41 Japan sickle cell anemia (HbS) testing & screening market estimates and forecasts for, hemoglobin electrophereis, by technology, 2016 - 2027 (USD Million)
Table 42 Japan sickle cell anemia (HbS) testing & screening market estimates and forecasts for, POC tests, by technology, 2016 - 2027 (USD Million)
Table 43 Japan sickle cell anemia (HbS) testing & screening market estimates and forecasts, by age group, 2016 - 2027 (USD Million)
Table 44 Japan sickle cell anemia (HbS) testing & screening market estimates and forecasts, by sector type, 2016 - 2027 (USD Million)
Table 45 China sickle cell anemia (HbS) testing & screening market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
Table 46 China sickle cell anemia (HbS) testing & screening market estimates and forecasts for, hemoglobin electrophereis, by technology, 2016 - 2027 (USD Million)
Table 47 China sickle cell anemia (HbS) testing & screening market estimates and forecasts for, POC tests, by technology, 2016 - 2027 (USD Million)
Table 48 China sickle cell anemia (HbS) testing & screening market estimates and forecasts, by age group, 2016 - 2027 (USD Million)
Table 49 China sickle cell anemia (HbS) testing & screening market estimates and forecasts, by sector type, 2016 - 2027 (USD Million)
Table 50 India sickle cell anemia (HbS) testing & screening market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
Table 51 India sickle cell anemia (HbS) testing & screening market estimates and forecasts for, hemoglobin electrophereis, by technology, 2016 - 2027 (USD Million)
Table 52 India sickle cell anemia (HbS) testing & screening market estimates and forecasts for, POC tests, by technology, 2016 - 2027 (USD Million)
Table 53 India sickle cell anemia (HbS) testing & screening market estimates and forecasts, by age group, 2016 - 2027 (USD Million)
Table 54 India sickle cell anemia (HbS) testing & screening market estimates and forecasts, by sector type, 2016 - 2027 (USD Million)
Table 55 Latin America sickle cell anemia (HbS) testing & screening market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
Table 56 Latin America sickle cell anemia (HbS) testing & screening market estimates and forecasts for, hemoglobin electrophereis, by technology, 2016 - 2027 (USD Million)
Table 57 Latin America. sickle cell anemia (HbS) testing & screening market estimates and forecasts for, POC tests, by technology, 2016 - 2027 (USD Million)
Table 58 Latin America sickle cell anemia (HbS) testing & screening market estimates and forecasts, by age group, 2016 - 2027 (USD Million)
Table 59 Latin America sickle cell anemia (HbS) testing & screening market estimates and forecasts, by sector type, 2016 - 2027 (USD Million)
Table 60 Brazil sickle cell anemia (HbS) testing & screening market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
Table 61 Brazil sickle cell anemia (HbS) testing & screening market estimates and forecasts for, hemoglobin electrophereis, by technology, 2016 - 2027 (USD Million)
Table 62 Brazil sickle cell anemia (HbS) testing & screening market estimates and forecasts for, POC tests, by technology, 2016 - 2027 (USD Million)
Table 63 Brazil sickle cell anemia (HbS) testing & screening market estimates and forecasts, by age group, 2016 - 2027 (USD Million)
Table 64 Brazil sickle cell anemia (HbS) testing & screening market estimates and forecasts, by sector type, 2016 - 2027 (USD Million)
Table 65 MEA sickle cell anemia (HbS) testing & screening market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
Table 66 MEA sickle cell anemia (HbS) testing & screening market estimates and forecasts for, hemoglobin electrophereis, by technology, 2016 - 2027 (USD Million)
Table 67 MEA. sickle cell anemia (HbS) testing & screening market estimates and forecasts for, POC tests, by technology, 2016 - 2027 (USD Million)
Table 68 MEA sickle cell anemia (HbS) testing & screening market estimates and forecasts, by age group, 2016 - 2027 (USD Million)
Table 69 MEA sickle cell anemia (HbS) testing & screening market estimates and forecasts, by sector type, 2016 - 2027 (USD Million)
Table 70 South Africa sickle cell anemia (HbS) testing & screening market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
Table 71 South Africa sickle cell anemia (HbS) testing & screening market estimates and forecasts for, hemoglobin electrophereis, by technology, 2016 - 2027 (USD Million)
Table 72 South Africa sickle cell anemia (HbS) testing & screening market estimates and forecasts for, POC tests, by technology, 2016 - 2027 (USD Million)
Table 73 South Africa sickle cell anemia (HbS) testing & screening market estimates and forecasts, by age group, 2016 - 2027 (USD Million)
Table 74 South Africa sickle cell anemia (HbS) testing & screening market estimates and forecasts, by sector type, 2016 - 2027 (USD Million?
Table 1 Comparative analysis of commercial tests available for screening sickle cell anemia population
Table 2 Top 10 laboratories offering sickle cell anemia screening tests, India
Table 3 List of secondary sources
Table 4 Prioritization of recommendations for newborn/neonatal screening
Table 5 North America sickle cell anemia (HbS) testing & screening market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
Table 6 North America sickle cell anemia (HbS) testing & screening market estimates and forecasts for, hemoglobin electrophereis, by technology, 2016 - 2027 (USD Million)
Table 7 North America. sickle cell anemia (HbS) testing & screening market estimates and forecasts for, POC tests, by technology, 2016 - 2027 (USD Million)
Table 8 North America sickle cell anemia (HbS) testing & screening market estimates and forecasts, by age group, 2016 - 2027 (USD Million)
Table 9 North America sickle cell anemia (HbS) testing & screening market estimates and forecasts, by sector type, 2016 - 2027 (USD Million)
Table 10 U.S. sickle cell anemia (HbS) testing & screening market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
Table 11 U.S. sickle cell anemia (HbS) testing & screening market estimates and forecasts for, hemoglobin electrophereis, by technology, 2016 - 2027 (USD Million)
Table 12 U.S. sickle cell anemia (HbS) testing & screening market estimates and forecasts for, POC tests, by technology, 2016 - 2027 (USD Million)
Table 13 U.S. sickle cell anemia (HbS) testing & screening market estimates and forecasts, by age group, 2016 - 2027 (USD Million)
Table 14 U.S. sickle cell anemia (HbS) testing & screening market estimates and forecasts, by sector type, 2016 - 2027 (USD Million)
Table 15 Canada sickle cell anemia (HbS) testing & screening market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
Table 16 Canada sickle cell anemia (HbS) testing & screening market estimates and forecasts for, hemoglobin electrophereis, by technology, 2016 - 2027 (USD Million)
Table 17 Canada sickle cell anemia (HbS) testing & screening market estimates and forecasts for, POC tests, by technology, 2016 - 2027 (USD Million)
Table 18 Canada sickle cell anemia (HbS) testing & screening market estimates and forecasts, by age group, 2016 - 2027 (USD Million)
Table 19 Canada sickle cell anemia (HbS) testing & screening market estimates and forecasts, by sector type, 2016 - 2027 (USD Million)
Table 20 Europe sickle cell anemia (HbS) testing & screening market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
Table 21 Europe sickle cell anemia (HbS) testing & screening market estimates and forecasts for, hemoglobin electrophereis, by technology, 2016 - 2027 (USD Million)
Table 22 Europe. sickle cell anemia (HbS) testing & screening market estimates and forecasts for, POC tests, by technology, 2016 - 2027 (USD Million)
Table 23 Europe sickle cell anemia (HbS) testing & screening market estimates and forecasts, by age group, 2016 - 2027 (USD Million)
Table 24 Europe sickle cell anemia (HbS) testing & screening market estimates and forecasts, by sector type, 2016 - 2027 (USD Million)
Table 25 Germany sickle cell anemia (HbS) testing & screening market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
Table 26 Germany sickle cell anemia (HbS) testing & screening market estimates and forecasts for, hemoglobin electrophereis, by technology, 2016 - 2027 (USD Million)
Table 27 Germany sickle cell anemia (HbS) testing & screening market estimates and forecasts for, POC tests, by technology, 2016 - 2027 (USD Million)
Table 28 Germany sickle cell anemia (HbS) testing & screening market estimates and forecasts, by age group, 2016 - 2027 (USD Million)
Table 29 Germany sickle cell anemia (HbS) testing & screening market estimates and forecasts, by sector type, 2016 - 2027 (USD Million)
Table 30 U.K. sickle cell anemia (HbS) testing & screening market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
Table 31 U.K. sickle cell anemia (HbS) testing & screening market estimates and forecasts for, hemoglobin electrophereis, by technology, 2016 - 2027 (USD Million)
Table 32 U.K. sickle cell anemia (HbS) testing & screening market estimates and forecasts for, POC tests, by technology, 2016 - 2027 (USD Million)
Table 33 U.K. sickle cell anemia (HbS) testing & screening market estimates and forecasts, by age group, 2016 - 2027 (USD Million)
Table 34 U.K. sickle cell anemia (HbS) testing & screening market estimates and forecasts, by sector type, 2016 - 2027 (USD Million)
Table 35 Asia Pacific sickle cell anemia (HbS) testing & screening market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
Table 36 Asia Pacific sickle cell anemia (HbS) testing & screening market estimates and forecasts for, hemoglobin electrophereis, by technology, 2016 - 2027 (USD Million)
Table 37 Asia Pacific. sickle cell anemia (HbS) testing & screening market estimates and forecasts for, POC tests, by technology, 2016 - 2027 (USD Million)
Table 38 Asia Pacific sickle cell anemia (HbS) testing & screening market estimates and forecasts, by age group, 2016 - 2027 (USD Million)
Table 39 Asia Pacific sickle cell anemia (HbS) testing & screening market estimates and forecasts, by sector type, 2016 - 2027 (USD Million)
Table 40 Japan sickle cell anemia (HbS) testing & screening market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
Table 41 Japan sickle cell anemia (HbS) testing & screening market estimates and forecasts for, hemoglobin electrophereis, by technology, 2016 - 2027 (USD Million)
Table 42 Japan sickle cell anemia (HbS) testing & screening market estimates and forecasts for, POC tests, by technology, 2016 - 2027 (USD Million)
Table 43 Japan sickle cell anemia (HbS) testing & screening market estimates and forecasts, by age group, 2016 - 2027 (USD Million)
Table 44 Japan sickle cell anemia (HbS) testing & screening market estimates and forecasts, by sector type, 2016 - 2027 (USD Million)
Table 45 China sickle cell anemia (HbS) testing & screening market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
Table 46 China sickle cell anemia (HbS) testing & screening market estimates and forecasts for, hemoglobin electrophereis, by technology, 2016 - 2027 (USD Million)
Table 47 China sickle cell anemia (HbS) testing & screening market estimates and forecasts for, POC tests, by technology, 2016 - 2027 (USD Million)
Table 48 China sickle cell anemia (HbS) testing & screening market estimates and forecasts, by age group, 2016 - 2027 (USD Million)
Table 49 China sickle cell anemia (HbS) testing & screening market estimates and forecasts, by sector type, 2016 - 2027 (USD Million)
Table 50 India sickle cell anemia (HbS) testing & screening market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
Table 51 India sickle cell anemia (HbS) testing & screening market estimates and forecasts for, hemoglobin electrophereis, by technology, 2016 - 2027 (USD Million)
Table 52 India sickle cell anemia (HbS) testing & screening market estimates and forecasts for, POC tests, by technology, 2016 - 2027 (USD Million)
Table 53 India sickle cell anemia (HbS) testing & screening market estimates and forecasts, by age group, 2016 - 2027 (USD Million)
Table 54 India sickle cell anemia (HbS) testing & screening market estimates and forecasts, by sector type, 2016 - 2027 (USD Million)
Table 55 Latin America sickle cell anemia (HbS) testing & screening market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
Table 56 Latin America sickle cell anemia (HbS) testing & screening market estimates and forecasts for, hemoglobin electrophereis, by technology, 2016 - 2027 (USD Million)
Table 57 Latin America. sickle cell anemia (HbS) testing & screening market estimates and forecasts for, POC tests, by technology, 2016 - 2027 (USD Million)
Table 58 Latin America sickle cell anemia (HbS) testing & screening market estimates and forecasts, by age group, 2016 - 2027 (USD Million)
Table 59 Latin America sickle cell anemia (HbS) testing & screening market estimates and forecasts, by sector type, 2016 - 2027 (USD Million)
Table 60 Brazil sickle cell anemia (HbS) testing & screening market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
Table 61 Brazil sickle cell anemia (HbS) testing & screening market estimates and forecasts for, hemoglobin electrophereis, by technology, 2016 - 2027 (USD Million)
Table 62 Brazil sickle cell anemia (HbS) testing & screening market estimates and forecasts for, POC tests, by technology, 2016 - 2027 (USD Million)
Table 63 Brazil sickle cell anemia (HbS) testing & screening market estimates and forecasts, by age group, 2016 - 2027 (USD Million)
Table 64 Brazil sickle cell anemia (HbS) testing & screening market estimates and forecasts, by sector type, 2016 - 2027 (USD Million)
Table 65 MEA sickle cell anemia (HbS) testing & screening market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
Table 66 MEA sickle cell anemia (HbS) testing & screening market estimates and forecasts for, hemoglobin electrophereis, by technology, 2016 - 2027 (USD Million)
Table 67 MEA. sickle cell anemia (HbS) testing & screening market estimates and forecasts for, POC tests, by technology, 2016 - 2027 (USD Million)
Table 68 MEA sickle cell anemia (HbS) testing & screening market estimates and forecasts, by age group, 2016 - 2027 (USD Million)
Table 69 MEA sickle cell anemia (HbS) testing & screening market estimates and forecasts, by sector type, 2016 - 2027 (USD Million)
Table 70 South Africa sickle cell anemia (HbS) testing & screening market estimates and forecasts, by technology, 2016 - 2027 (USD Million)
Table 71 South Africa sickle cell anemia (HbS) testing & screening market estimates and forecasts for, hemoglobin electrophereis, by technology, 2016 - 2027 (USD Million)
Table 72 South Africa sickle cell anemia (HbS) testing & screening market estimates and forecasts for, POC tests, by technology, 2016 - 2027 (USD Million)
Table 73 South Africa sickle cell anemia (HbS) testing & screening market estimates and forecasts, by age group, 2016 - 2027 (USD Million)
Table 74 South Africa sickle cell anemia (HbS) testing & screening market estimates and forecasts, by sector type, 2016 - 2027 (USD Million?
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Sickle cell anemia (HbS) testing & screening market: Primary research analysis
Fig. 5 Sickle cell anemia testing & screening segment revenue modeling
Fig. 6 Sickle cell anemia testing & screening market revenue modeling
Fig. 7 Sickle cell anemia testing & screening market age group revenue modeling
Fig. 8 Sickle cell anemia testing & screening newborn screening algorithm
Fig. 9 Sample load analysis across laboratories, tier - wise
Fig. 10 Sickle cell anemia testing & screening market regional revenue modeling
Fig. 11 Sickle cell anemia testing & screening market regional revenue modeling
Fig. 12 Market research approaches
Fig. 13 Value-chain based sizing & forecasting
Fig. 14 QFD modeling for market share assessment
Fig. 15 Market formulation & validation
Fig. 16 Sickle cell anemia (HbS) testing & screening market snapshot
Fig. 17 Sickle cell anemia (HbS) testing & screening market segmentation
Fig. 18 Sickle cell anemia (HbS) testing & screening, parent market outlook
Fig. 19 Penetration and growth prospect mapping
Fig. 20 Sickle cell anemia (HbS) testing & screening market driver impact
Fig. 21 Strategies to minimize the sickle cell disease burden
Fig. 22 Prevalence of sickle - cell anemia across the globe & India, 2016 - 2019
Fig. 23 Babies with sickle - cell anemia across the globe & India, 2016 - 2019
Fig. 24 Prevalence rate of sickle - cell anemia across the globe & India, 2016 - 2019 (%)
Fig. 25 Sickle cell anemia (HbS) testing & screening market restraint impact
Fig. 26 Sickle cell anemia (HbS) testing & screening market opportunity impact
Fig. 27 Sickle cell anemia (HbS) testing & screening market SWOT analysis
Fig. 28 Sickle cell anemia (HbS) testing & screening market Porter’s five forces analysis
Fig. 29 Ansoff Matrix
Fig. 30 Competition Categorization
Fig. 31 Factors impacting market entry strategies
Fig. 32 Sickle Cell Anemia (HbS) Testing & Screening market: Technology outlook and key takeaways
Fig. 33 Sickle Cell Anemia (HbS) Testing & Screening market: Technology movement analysis
Fig. 34 Hb electrophoresis - based sickle cell anemia (HbS) testing & screening market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 35 Hb electrophoresis - based sickle cell anemia (HbS) testing & screening market estimates and forecasts, 2016 - 2027 (Volume of Tests, Thousand Units)
Fig. 36 Isoelectric focusing based sickle cell anemia (HbS) testing & screening market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 37 Isoelectric focusing based sickle cell anemia (HbS) testing & screening market estimates and forecasts, 2016 - 2027 (Volume of Tests, Thousand Units)
Fig. 38 Other sickle cell anemia (HbS) testing & screening market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 39 Other sickle cell anemia (HbS) testing & screening market estimates and forecasts, 2016 - 2027 (Volume of Tests, Thousand Units)
Fig. 40 HPLC - based sickle cell anemia (HbS) testing & screening market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 41 HPLC - based sickle cell anemia (HbS) testing & screening market estimates and forecasts, 2016 - 2027 (Volume of Tests, Thousand Units)
Fig. 42 POC sickle cell anemia (HbS) testing & screening market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 43 POC sickle cell anemia (HbS) testing & screening market estimates and forecasts, 2016 - 2027 (Volume of Tests, Thousand Units)
Fig. 44 Lateral flow POC sickle cell anemia (HbS) testing & screening market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 45 Lateral flow POC sickle cell anemia (HbS) testing & screening market estimates and forecasts, 2016 - 2027 (Volume of Tests, Thousand Units)
Fig. 46 Paper based POC sickle cell anemia (HbS) testing & screening market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 47 Paper base POC sickle cell anemia (HbS) testing & screening market estimates and forecasts, 2016 - 2027 (Volume of Tests, Thousand Units)
Fig. 48 Other POC sickle cell anemia (HbS) testing & screening market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 49 Other POC sickle cell anemia (HbS) testing & screening market estimates and forecasts, 2016 - 2027 (Volume of Tests, Thousand Units)
Fig. 50 Other sickle cell anemia (HbS) testing & screening market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 51 Other sickle cell anemia (HbS) testing & screening market estimates and forecasts, 2016 - 2027 (Volume of Tests, Thousand Units)
Fig. 52 Sickle cell anemia (HbS) testing & screening market: Age group outlook and key takeaways
Fig. 53 Sickle cell anemia (HbS) testing & screening market: Age group movement analysis
Fig. 54 Sickle cell anemia (HbS) newborn testing & screening market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 55 Sickle cell anemia (HbS) adult testing & screening market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 56 Sickle cell anemia (HbS) testing & screening market for other age groups estimates and forecast, 2016 - 2027 (USD Million)
Fig. 57 Sickle cell anemia (HbS) testing & screening market: Sector type outlook and key takeaways
Fig. 58 Sickle cell anemia (HbS) testing & screening market: Sector type movement analysis
Fig. 59 Sickle cell disease government initiatives: U.S.
Fig. 60 Sickle cell anemia (HbS) testing & screening market for government labs estimates and forecast, 2016 - 2027
Fig. 61 Sickle cell anemia (HbS) testing & screening market for private labs estimates and forecast, 2016 - 2027
Fig. 62 Sickle cell anemia (HbS) testing & screening market for corporate labs estimates and forecast, 2016 - 2027
Fig. 63 Sickle cell anemia (HbS) testing & screening market for PPP (public - private - partnerships) estimates and forecast, 2016 - 2027
Fig64 Sickle cell anemia (HbS) testing & screening market: Regional outlook and key takeaways
Fig. 65 Sickle cell anemia (HbS) testing & screening market: Regional movement analysis
Fig. 66 North America sickle cell anemia (HbS) testing & screening market overview
Fig. 67 North America sickle cell anemia (HbS) testing & screening market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 68 U.S.
Fig. 69 U.S. sickle cell anemia (HbS) testing & screening market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 70 Canada sickle cell anemia (HbS) testing & screening market overview
Fig. 71 Canada sickle cell anemia (HbS) testing & screening market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 72 Europe Sickle Cell Anemia (HbS) Testing & Screening market overview
Fig. 73 Europe sickle cell anemia (HbS) testing & screening market estimates and forecast, 2016 - 2027 (USD Million)
Fig 74 Germany sickle cell anemia (HbS) testing & screening market overview
Fig. 75 Germany Sickle Cell Anemia (HbS) Testing & Screening market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 76 U.K. sickle cell anemia (HbS) testing & screening market overview
Fig. 77 U.K. sickle cell anemia (HbS) testing & screening market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 78 Asia Pacific Sickle Cell Anemia (HbS) Testing & Screening market overview
Fig. 79 Asia Pacific Sickle Cell Anemia (HbS) Testing & Screening market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 80 Japan sickle cell anemia (HbS) testing & screening market overview
Fig. 81 Japan Sickle Cell Anemia (HbS) Testing & Screening market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 82 China sickle cell anemia (HbS) testing & screening market overview
Fig. 83 China Sickle Cell Anemia (HbS) Testing & Screening market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 84 India Sickle Cell Anemia (HbS) Testing & Screening market overview
Fig. 85 India Sickle Cell Anemia (HbS) Testing & Screening market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 86 Latin America sickle cell anemia (HbS) testing & screening market overview
Fig. 87 Latin America sickle cell anemia (HbS) testing & screening market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 88 Brazil Sickle Cell Anemia (HbS) Testing & Screening market overview
Fig. 89 Brazil Sickle Cell Anemia (HbS) Testing & Screening market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 90 Middle East & Africa Sickle Cell Anemia (HbS) Testing & Screening market overview
Fig. 91 MEA sickle cell anemia (HbS) Testing & Screening market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 92 South Africa sickle cell anemia (HbS) testing & screening market overview
Fig. 93 South Africa sickle cell anemia (HbS) testing & screening market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Sickle cell anemia (HbS) testing & screening market: Primary research analysis
Fig. 5 Sickle cell anemia testing & screening segment revenue modeling
Fig. 6 Sickle cell anemia testing & screening market revenue modeling
Fig. 7 Sickle cell anemia testing & screening market age group revenue modeling
Fig. 8 Sickle cell anemia testing & screening newborn screening algorithm
Fig. 9 Sample load analysis across laboratories, tier - wise
Fig. 10 Sickle cell anemia testing & screening market regional revenue modeling
Fig. 11 Sickle cell anemia testing & screening market regional revenue modeling
Fig. 12 Market research approaches
Fig. 13 Value-chain based sizing & forecasting
Fig. 14 QFD modeling for market share assessment
Fig. 15 Market formulation & validation
Fig. 16 Sickle cell anemia (HbS) testing & screening market snapshot
Fig. 17 Sickle cell anemia (HbS) testing & screening market segmentation
Fig. 18 Sickle cell anemia (HbS) testing & screening, parent market outlook
Fig. 19 Penetration and growth prospect mapping
Fig. 20 Sickle cell anemia (HbS) testing & screening market driver impact
Fig. 21 Strategies to minimize the sickle cell disease burden
Fig. 22 Prevalence of sickle - cell anemia across the globe & India, 2016 - 2019
Fig. 23 Babies with sickle - cell anemia across the globe & India, 2016 - 2019
Fig. 24 Prevalence rate of sickle - cell anemia across the globe & India, 2016 - 2019 (%)
Fig. 25 Sickle cell anemia (HbS) testing & screening market restraint impact
Fig. 26 Sickle cell anemia (HbS) testing & screening market opportunity impact
Fig. 27 Sickle cell anemia (HbS) testing & screening market SWOT analysis
Fig. 28 Sickle cell anemia (HbS) testing & screening market Porter’s five forces analysis
Fig. 29 Ansoff Matrix
Fig. 30 Competition Categorization
Fig. 31 Factors impacting market entry strategies
Fig. 32 Sickle Cell Anemia (HbS) Testing & Screening market: Technology outlook and key takeaways
Fig. 33 Sickle Cell Anemia (HbS) Testing & Screening market: Technology movement analysis
Fig. 34 Hb electrophoresis - based sickle cell anemia (HbS) testing & screening market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 35 Hb electrophoresis - based sickle cell anemia (HbS) testing & screening market estimates and forecasts, 2016 - 2027 (Volume of Tests, Thousand Units)
Fig. 36 Isoelectric focusing based sickle cell anemia (HbS) testing & screening market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 37 Isoelectric focusing based sickle cell anemia (HbS) testing & screening market estimates and forecasts, 2016 - 2027 (Volume of Tests, Thousand Units)
Fig. 38 Other sickle cell anemia (HbS) testing & screening market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 39 Other sickle cell anemia (HbS) testing & screening market estimates and forecasts, 2016 - 2027 (Volume of Tests, Thousand Units)
Fig. 40 HPLC - based sickle cell anemia (HbS) testing & screening market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 41 HPLC - based sickle cell anemia (HbS) testing & screening market estimates and forecasts, 2016 - 2027 (Volume of Tests, Thousand Units)
Fig. 42 POC sickle cell anemia (HbS) testing & screening market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 43 POC sickle cell anemia (HbS) testing & screening market estimates and forecasts, 2016 - 2027 (Volume of Tests, Thousand Units)
Fig. 44 Lateral flow POC sickle cell anemia (HbS) testing & screening market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 45 Lateral flow POC sickle cell anemia (HbS) testing & screening market estimates and forecasts, 2016 - 2027 (Volume of Tests, Thousand Units)
Fig. 46 Paper based POC sickle cell anemia (HbS) testing & screening market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 47 Paper base POC sickle cell anemia (HbS) testing & screening market estimates and forecasts, 2016 - 2027 (Volume of Tests, Thousand Units)
Fig. 48 Other POC sickle cell anemia (HbS) testing & screening market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 49 Other POC sickle cell anemia (HbS) testing & screening market estimates and forecasts, 2016 - 2027 (Volume of Tests, Thousand Units)
Fig. 50 Other sickle cell anemia (HbS) testing & screening market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 51 Other sickle cell anemia (HbS) testing & screening market estimates and forecasts, 2016 - 2027 (Volume of Tests, Thousand Units)
Fig. 52 Sickle cell anemia (HbS) testing & screening market: Age group outlook and key takeaways
Fig. 53 Sickle cell anemia (HbS) testing & screening market: Age group movement analysis
Fig. 54 Sickle cell anemia (HbS) newborn testing & screening market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 55 Sickle cell anemia (HbS) adult testing & screening market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 56 Sickle cell anemia (HbS) testing & screening market for other age groups estimates and forecast, 2016 - 2027 (USD Million)
Fig. 57 Sickle cell anemia (HbS) testing & screening market: Sector type outlook and key takeaways
Fig. 58 Sickle cell anemia (HbS) testing & screening market: Sector type movement analysis
Fig. 59 Sickle cell disease government initiatives: U.S.
Fig. 60 Sickle cell anemia (HbS) testing & screening market for government labs estimates and forecast, 2016 - 2027
Fig. 61 Sickle cell anemia (HbS) testing & screening market for private labs estimates and forecast, 2016 - 2027
Fig. 62 Sickle cell anemia (HbS) testing & screening market for corporate labs estimates and forecast, 2016 - 2027
Fig. 63 Sickle cell anemia (HbS) testing & screening market for PPP (public - private - partnerships) estimates and forecast, 2016 - 2027
Fig64 Sickle cell anemia (HbS) testing & screening market: Regional outlook and key takeaways
Fig. 65 Sickle cell anemia (HbS) testing & screening market: Regional movement analysis
Fig. 66 North America sickle cell anemia (HbS) testing & screening market overview
Fig. 67 North America sickle cell anemia (HbS) testing & screening market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 68 U.S.
Fig. 69 U.S. sickle cell anemia (HbS) testing & screening market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 70 Canada sickle cell anemia (HbS) testing & screening market overview
Fig. 71 Canada sickle cell anemia (HbS) testing & screening market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 72 Europe Sickle Cell Anemia (HbS) Testing & Screening market overview
Fig. 73 Europe sickle cell anemia (HbS) testing & screening market estimates and forecast, 2016 - 2027 (USD Million)
Fig 74 Germany sickle cell anemia (HbS) testing & screening market overview
Fig. 75 Germany Sickle Cell Anemia (HbS) Testing & Screening market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 76 U.K. sickle cell anemia (HbS) testing & screening market overview
Fig. 77 U.K. sickle cell anemia (HbS) testing & screening market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 78 Asia Pacific Sickle Cell Anemia (HbS) Testing & Screening market overview
Fig. 79 Asia Pacific Sickle Cell Anemia (HbS) Testing & Screening market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 80 Japan sickle cell anemia (HbS) testing & screening market overview
Fig. 81 Japan Sickle Cell Anemia (HbS) Testing & Screening market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 82 China sickle cell anemia (HbS) testing & screening market overview
Fig. 83 China Sickle Cell Anemia (HbS) Testing & Screening market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 84 India Sickle Cell Anemia (HbS) Testing & Screening market overview
Fig. 85 India Sickle Cell Anemia (HbS) Testing & Screening market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 86 Latin America sickle cell anemia (HbS) testing & screening market overview
Fig. 87 Latin America sickle cell anemia (HbS) testing & screening market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 88 Brazil Sickle Cell Anemia (HbS) Testing & Screening market overview
Fig. 89 Brazil Sickle Cell Anemia (HbS) Testing & Screening market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 90 Middle East & Africa Sickle Cell Anemia (HbS) Testing & Screening market overview
Fig. 91 MEA sickle cell anemia (HbS) Testing & Screening market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 92 South Africa sickle cell anemia (HbS) testing & screening market overview
Fig. 93 South Africa sickle cell anemia (HbS) testing & screening market estimates and forecast, 2016 - 2027 (USD Million)
